Directory
>
Tassos Georgiadis
Tassos Georgiadis
Vice President Preclinical Development | MeiraGTx
London, England, United Kingdom
Tassos Georgiadis
Summary
Tassos Georgiadis is a seasoned professional in the field of genetic medicine, currently serving as the Vice President of Preclinical Development at MeiraGTx. With a robust background in molecular genetics and extensive experience in developing AAV-based gene therapies, he is dedicated to creating transformative treatments for patients with limited options. His journey from research assistant to a leadership role showcases his commitment to advancing therapeutic solutions through innovative science. Notably, he has a strong focus on improving clinical outcomes by leveraging both in vivo and in vitro biological systems. His academic foundation includes a PhD in Molecular Genetics from University College London, further enhancing his expertise in the field. Outside of his technical skills, he is passionate about mentoring the next generation of scientists and fostering a collaborative research environment.
Tassos Georgiadis
Work Experience
Vice President Preclinical Development at
MeiraGTx
November 2021 - Present
Senior Director of Preclinical Development at
MeiraGTx
November 2018 - October 2021
Senior Research Associate at
UNIVERSITY COLLEGE LONDON
October 2015 - October 2018
Research Associate at
UNIVERSITY COLLEGE LONDON
January 2009 - September 2015
Research Assistant at
UNIVERSITY COLLEGE LONDON
January 2002 - January 2005
Tassos Georgiadis
Education
University College London, Phd
January 2005 - January 2009
January 2001 - January 2002
Queen Mary, U. of London, Bsc
January 1997 - January 2000
Frequently Asked Questions about Tassos Georgiadis
What is Tassos Georgiadis email address?
Tassos Georgiadis's primary email address is *****************@meiragtx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Tassos Georgiadis work for?
Tassos Georgiadis is a Vice President Preclinical Development at MeiraGTx, a company specializing in Commercial physical research.
Where Tassos Georgiadis graduated from?
Tassos Georgiadis holds a degree in Molecular Genetics from University College London.
How can I directly contact Tassos Georgiadis?
To contact Tassos Georgiadis directly, you can use the email address *****************@meiragtx.com. Complete contact information is available upon registration with Muraena.
Who is Tassos Georgiadis?
Tassos Georgiadis is a seasoned professional in the field of genetic medicine, currently serving as the Vice President of Preclinical Development at MeiraGTx. With a robust background in molecular genetics and extensive experience in developing AAV-based gene therapies, he is dedicated to creating transformative treatments for patients with limited options. His journey from research assistant to a leadership role showcases his commitment to advancing therapeutic solutions through innovative science. Notably, he has a strong focus on improving clinical outcomes by leveraging both in vivo and in vitro biological systems. His academic foundation includes a PhD in Molecular Genetics from University College London, further enhancing his expertise in the field. Outside of his technical skills, he is passionate about mentoring the next generation of scientists and fostering a collaborative research environment.
Tassos`s contact details
*****************@meiragtx.com
Colleagues
VP MSAT
Chief Operating Officer
Chief Medical Officer
Vice President, Salivary Gland Therapeutics Lead
Executive Director, CMC Regulatory Affairs
Chief Executive Officer
VP, Biostatistics
VP Clinical Research and Ophthalmology
Senior Vice President, Head of Business Development